Telehealth Prescriptions Bring Oral Tirzepatide Straight to Home

Health Points

• Telehealth primary care visits rose sharply from 1.4 million per quarter in 2018, reflecting sustained consumer preference for remote care.
• Oral tirzepatide prescriptions through telehealth services deliver medication directly to the doorstep, removing traditional office visits.
• Convenience and privacy remain central reasons adults over 40 continue choosing at-home prescription pathways.

Telehealth primary care visits in the second quarter of 2018 hovered around 1.4 million per quarter, according to IQVIA data. Two years later, that number had multiplied many times over, and demand has remained steady since.

Patients seeking oral tirzepatide now complete an online questionnaire, consult a licensed clinician via video, and receive medication shipped to their door. The entire process bypasses waiting rooms and travel time.

Many adults over 40 cite privacy, scheduling flexibility, and reduced exposure in medical offices as key motivators. Telehealth platforms report that repeat prescription refills through the same system are rising each quarter.

Clinicians emphasize that candidates still undergo appropriate screening, lab review, and follow-up, even when care is delivered remotely. Ongoing monitoring remains an integral part of responsible prescribing.

Delivery logistics have also improved, with most prescriptions arriving in temperature-stable packaging within two business days. Patients appreciate the streamlined experience that integrates medical oversight with home convenience.